Safety of rituximab in lymphoma patients with hepatitis B or hepatitis C virus infection

Hematol J. 2003;4(2):159-62. doi: 10.1038/sj.thj.6200243.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Female
  • Hepatitis B / complications*
  • Hepatitis C / complications*
  • Humans
  • Liver Cirrhosis / virology
  • Lymphoma / complications
  • Lymphoma / drug therapy*
  • Male
  • Middle Aged
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab